1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. QUOIN PHARMACEUTICALS LTD - ADR
Quoin Pharmaceuticals Ltd - ADR
XNAS: QNRX
7.26 -0.61 (-7.75%)
78,713
XNAS Volume

XNAS 04 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert



Insider Trading disclosures for Quoin Pharma Ltd (ADR)

The latest disclosure was made by Bridget Sally Lawlor in Quoin Pharma Ltd (ADR) where a trade of 85,250 Share Option (Right to Buy) done was reported to US exchanges on Feb. 4, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Bridget Sally Lawlor Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2026 85,250 85,250 - - Share Option (Right to Buy)
Natalie Leong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2026 12,211 12,211 - - Share Option (Right to Buy)
Denise Carter Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2026 318,750 318,750 - - Share Option (Right to Buy)
Michael Myers Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2026 318,750 318,750 - - Share Option (Right to Buy)
Anthony James Culverwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2026 21,709 21,709 - - Share Option (Right to Buy)
Joseph P. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2026 8,141 8,141 - - Share Option (Right to Buy)
Dennis H. Langer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2026 21,709 21,709 - - Share Option (Right to Buy)
Bridget Sally Lawlor Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2025 10,330 10,330 - - Share Option (Right to Buy)
Dennis H. Langer Director Purchase of securities on an exchange or from another person at price $ 8.49 per share. 14 Oct 2025 15,152 15,153 - 8.5 128,640 ADSs
Dennis H. Langer Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Oct 2025 15,152 15,152 - - Series H Warrants (Right to Buy)
Dennis H. Langer Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Oct 2025 15,152 15,152 - - Series I Warrants (Right to Buy)
Dennis H. Langer Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Oct 2025 15,152 15,152 - - Series J Warrants (Right to Buy)
Dennis H. Langer Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Oct 2025 15,152 15,152 - - Series K Warrants (Right to Buy)
Natalie Leong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Aug 2025 4,105 4,105 - - Share Option (Right to Buy)
Dennis H. Langer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Aug 2025 13,682 13,682 - - Share Option (Right to Buy)
Anthony James Culverwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Aug 2025 13,682 13,682 - - Share Option (Right to Buy)
Denise Carter Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2025 42,857 42,857 - - Share Option (Right to Buy)
Michael Myers Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2025 42,857 42,857 - - Share Option (Right to Buy)
Natalie Leong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2025 7,760 7,760 - - Share Option (Right to Buy)
Denise Carter Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2025 42,039 42,039 - - Share Option (Right to Buy)
Michael Myers Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2025 42,039 42,039 - - Share Option (Right to Buy)
Anthony James Culverwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2025 7,760 7,760 - - Share Option (Right to Buy)
Joseph P. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2025 7,760 7,760 - - Share Option (Right to Buy)
Dennis H. Langer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2025 7,760 7,760 - - Share Option (Right to Buy)
Myers Michael Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 555,556 555,556 - - Series G Warrants (right to buy)
Culverwell James Anthony Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 100,000 100,000 - - Series G Warrants (right to buy)
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 122,221 122,221 - - Series F Warrants (right to buy)
Carter Denise Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 555,556 555,556 - - Series F Warrants (right to buy)
Michael Myers Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 555,556 555,556 - - Series F Warrants (right to buy)
Dunn Gordon Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.45 per share. 23 Dec 2024 122,221 151,077 - 0.4 54,999 Ordinary Shares
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 555,556 555,556 - - Series G Warrants (right to buy)
Myers Michael Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.45 per share. 23 Dec 2024 555,556 602,808 - 0.4 250,000 Ordinary Shares
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 122,221 122,221 - - Series G Warrants (right to buy)
Anthony James Culverwell Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Dec 2024 100,000 100,000 - - Series F Warrants (right to buy)
Anthony James Culverwell Director Purchase of securities on an exchange or from another person at price $ 0.45 per share. 23 Dec 2024 100,000 100,317 - 0.5 45,000 Ordinary Shares
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.45 per share. 23 Dec 2024 555,556 602,648 - 0.4 250,000 Ordinary Shares
Dennis H. Langer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 50,714 50,714 - - Share Option (Right to Buy)
Joseph P. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 50,714 50,714 - - Share Option (Right to Buy)
Gordon Dunn Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 338,994 338,994 - - Share Option (Right to Buy)
Anthony James Culverwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 50,714 50,714 - - Share Option (Right to Buy)
Denise Carter Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 536,609 536,609 - - Share Option (Right to Buy)
Natalie Leong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 50,714 50,714 - - Share Option (Right to Buy)
Michael Myers Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 536,603 536,603 - - Share Option (Right to Buy)
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.80 per share. 09 Sep 2024 4,000 8,856 - 0.8 3,200 Ordinary Shares
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.91 per share. 09 Sep 2024 10,000 18,856 - 0.9 9,100 Ordinary Shares
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.71 per share. 09 Sep 2024 10,000 28,856 - 0.7 7,100 Ordinary Shares
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.80 per share. 09 Sep 2024 856 856 - 0.8 685 Ordinary Shares
Gordon Dunn Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.78 per share. 09 Sep 2024 4,000 4,856 - 0.8 3,120 Ordinary Shares
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.75 per share. 03 Sep 2024 8,825 24,104 - 0.7 6,602 Ordinary Shares
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.66 per share. 03 Sep 2024 4,100 15,279 - 0.7 2,686 Ordinary Shares
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.63 per share. 03 Sep 2024 1,822 11,179 - 0.6 1,139 Ordinary Shares
Denise Carter Director, Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 0.80 per share. 03 Sep 2024 22,988 47,092 - 0.8 18,310 Ordinary Shares
Michael Myers Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.75 per share. 03 Sep 2024 8,200 23,680 - 0.7 6,134 Ordinary Shares
Michael Myers Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.66 per share. 03 Sep 2024 5,322 15,480 - 0.7 3,490 Ordinary Shares
Michael Myers Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.62 per share. 03 Sep 2024 800 10,158 - 0.6 495 Ordinary Shares
Michael Myers Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.80 per share. 03 Sep 2024 23,572 47,252 - 0.8 18,796 Ordinary Shares
Dennis H. Langer Director Sale of securities on an exchange or to another person at price $ 0.73 per share. 07 Jun 2024 297 53 - 0.7 217 Ordinary Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures